Leading the Way in Medical Device Technology

FORA’s pursuit for excellence never stops. We are dedicated to the development of unique technology and currently hold worldwide patents for IR thermometer, blood glucose meter, test strip, cardiovascular care products, and other medical related applications.

Leading the Way in Medical Device Technology

As ForaCare continues to strive for excellence in clinical competency, our blood glucose monitoring systems continue to meet the emerging needs of higher accuracy in blood glucose measurement and meet the new FDA criteria of ±15%.

As ForaCare continues to strive for excellence in clinical competency, our blood glucose monitoring systems continue to meet the emerging needs of higher accuracy in blood glucose measurement and meet the new FDA criteria of ±15%.

Introducing Blood Glucose and β-Ketone Test Strips for the Same Meter

Our advanced and innovative Gold Strip Technology, assures that blood glucose and ketone readings are accurate and reliable.

Our advanced and innovative Gold Strip Technology, assures that blood glocouse and ketone readings are accurate and reliable.

Exceeding Current FDA Standards

FORA Test N’GO Advance Strip Accuracy

100%

100% of glucose levels within ±20% of lab reference values.
FDA Standard: 99% (2,4)

98.7%

98.7% of glucose levels within ±15% of lab reference values.
FDA Standard: 95% (2,4)

±8.6%

FORA Test N’GO Advance strip accuracy is within ± 8.6% of lab values. (3*)

References:

1. Food and Drug Administration. Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Guidance for Industry and Food and Drug Administration Staff. Document issued on: October 11, 2016.

2. Food and Drug Administration. Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use Guidance for Industry and Food and Drug Administration Staff. Document issued on October 11, 2016.

3. System Accuracy Evaluation of FORA GoldAdvance Plus Blood Glucose Monitoring System versus YSI 2300 STAT Plus™ glucose analyzer following “Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Guidance for Industry and Food and Drug Administration Staff” * The results demonstrated that 95% of results fell within ±8.6% of the laboratory reference values when tested via subject–obtained venous or capillary blood.

4. System Accuracy Evaluation of FORA TD4122 Blood Glucose Monitoring System versus YSI 2300 STAT Plus™ glucose analyzer following “Blood Glucose Monitoring Test Systems for Over-the-Counter Use Guidance for Industry and Food and Drug Administration Staff”.

About ForaCare

ForaCare Inc. is a technology healthcare company dedicated to the design, development, and marketing of medical devices, and software for chronic disease management. As the new leader in medical device technology, we specialize in diabetes and hypertension medical devices, mobile applications and web-based Telehealth solutions.

With offices and customers around the world, ForaCare designs and manufactures technologically advanced, easy-to-use, and accurate products.